Emmaus life sciences, inc. (MYND)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

-62,267

-41,416

-41,627

-41,577

-41,642

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-5,239

-3,929

-5,940

-6,220

-5,402

-5,956

-3,379

-2,944

-3,426

-3,672

-2,662

-8,894

-9,209

-9,799

-10,907

265

5,214

-1,648

-3,406

-10,206

-12,948

-11,500

-8,866

0

0

0

Adjustments to reconcile net loss to net cash flows from operating activities
Valuation of warrants - investor relations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

21

21

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11

11

13

14

16

18

18

17

15

13

11

0

0

0

Amortization of discount of notes payable and convertible notes payable

19,502

13,072

13,072

13,080

13,061

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

5

0

0

0

-

-

-

-

3,544

4,292

5,023

4,976

4,197

0

0

0

Issuance of warrants for financing services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56

56

114

106

183

0

0

0

Loss on derivative liability valuation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-97

5,934

12,354

6,620

6,950

2,991

1,070

2,841

6,826

0

0

0

Amortization of discount on bridge notes issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Share-based compensation

1,620

3,958

4,261

4,260

4,079

2,126

1,690

1,921

2,086

1,889

1,752

1,295

834

277

150

219

241

373

504

707

1,008

1,110

1,230

1,265

1,257

1,327

1,373

1,370

1,350

1,390

1,430

1,506

1,605

0

0

0

Net loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-2

-8

-9

-10

-19

0

0

0

-

-

-

-

-

-

-

-

Depreciation and amortization

-

121

120

124

117

103

88

64

48

36

22

13

7

5

5

6

7

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in provision for doubtful accounts

-

4

5

3

0

2

1

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued to vendors for services

-

-96

-228

-192

-201

-186

-198

-187

-173

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of embedded conversion option

-

-

-

-

-

-

-

-

-

-

-

-

-34

1,013

893

214

162

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

572

-2,967

-2,967

-2,967

-630

0

0

0

1,105

1,105

1,105

1,195

556

0

0

0

-

-

-

-

-

-

-

-

Financing expenses

-

-

-

-

-

-

-

-

-

-

-

-

-2,717

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

622

733

751

730

664

675

1,158

1,484

3,366

0

0

0

Net changes in operating assets and liabilities
Accounts receivable

607

1,458

1,349

1,449

1,408

77

155

21

1

2

0

-0

-6

-8

1

-5

2

6

-1

-9

-17

-6

-11

0

14

2

14

12

-6

-19

-43

-24

-8

0

0

0

Prepaid expenses and other current assets

404

-203

-63

17

32

166

68

42

12

-54

-50

-35

-25

32

14

9

4

1

14

-6

-5

-6

-9

14

20

26

2

-24

-28

9

7

-3

-13

0

0

0

Accounts payable and accrued expenses

5,274

3,420

2,993

3,002

2,546

-505

97

174

301

333

215

-30

-182

-154

-157

0

-64

-80

103

-38

-153

-156

-273

-171

-63

56

987

1,156

1,386

1,803

1,250

755

640

0

0

0

Deferred revenue

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of grant of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

7

17

7

3

0

0

0

Deferred compensation exchange for common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Deferred compensation

-

0

0

0

-

-

-

-

-275

-41

13

84

51

103

276

308

302

250

79

-169

-421

-592

-558

-123

30

-40

192

-60

0

268

-138

32

49

0

0

0

Net cash flows used in operating activities

-6,820

-5,787

-6,271

-6,478

-7,175

-9,534

-7,931

-6,466

-4,792

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-3,537

-3,036

-2,418

-2,015

-2,039

-2,337

-2,299

-2,835

-3,239

-3,565

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,473

-2,152

-1,970

-2,156

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

59

74

63

85

109

96

98

154

127

88

87

5

4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment for acquisition of business, net of cash acquired

-

-

-

-

306

149

306

306

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs incurred to develop intangible assets

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

21

21

21

21

0

0

0

0

Acquisition of furniture & equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

6

5

7

21

0

0

0

Disposal of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

1

0

0

0

0

-

-

-

-

Net cash flows provided by (used in) investing activities

-1,479

5,863

5,875

5,852

5,522

-611

-752

-810

-479

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

1

1

1

-1

-25

-27

-27

-28

-21

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on note payable

-

-27

-19

-28

-36

-52

-90

-72

-56

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

0

0

0

Principal payments on capital lease

-

2

2

2

2

1

1

1

1

1

1

2

3

3

3

3

3

4

5

6

7

5

5

4

4

5

6

6

6

6

6

6

6

0

0

0

New equipment lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from notes payable issued, net of issuance cost and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,368

1,768

1,968

2,923

2,595

-2,204

155

-799

0

0

0

0

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

1,691

3,027

3,725

3,424

2,958

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale of common stock

-

-

-

-

-

-

-

-

-

-

-

3,450

2,950

2,835

2,295

2,350

1,350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

2,831

2,291

2,346

1,346

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows provided by (used in) financing activities

3,019

-6,759

-7,292

-7,013

-7,021

12,383

9,342

8,886

10,402

0

0

0

-

-

-

-

-

-

-

-

-

-

-

3,420

4,322

3,125

2,626

2,917

2,590

2,305

3,049

3,428

4,218

0

0

0

Net cash (used in) provided by continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61

-530

117

-117

1,287

0

0

0

-

-

-

-

-

-

-

-

Net cash used in discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Net Cash used in discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-76

-50

-40

-21

-47

-51

-153

-293

0

0

0

-

-

-

-

NET DECREASE IN CASH

-

-203

-1,209

-1,158

-2,194

2,237

657

1,609

5,130

-21

1,314

224

-113

289

130

378

-808

77

-473

-217

-33

-607

66

-158

1,265

660

560

722

-65

-893

-678

-592

18

0

0

0

SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES
Interest paid

1,240

1,782

1,783

1,784

1,786

7

11

7

6

7

3

5

4

3

3

3

3

3

4

4

4

4

4

3

3

5

6

6

9

8

5

5

3

0

0

0

Finance Fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

-

-

-

-

-

-

-

-

2

50

34

3

2

0

1

2

4

5

6

6

5

4

2

1

0

0

1

1

1

2

0

0

1

0

0

0

Long-term borrowings assumed in business combination

-

-

-

-

651

651

651

651

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

784

0

0

0

-

-

-

-

Offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

784

0

0

0

-

-

-

-

Shares issued for officer salaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Shares issued for accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

Fair value of intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0